Drosophila Contributions towards Understanding Neurofibromatosis 1
Cells · 2024
DOI: 10.3390/cells13080721 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2024. Verfasst von Kalliopi Atsoniou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center "Alexander Fleming", 16672 Athens, Greece. Hauptthemen laut MEDLINE: Neurofibromatosis 1, Disease Models, Animal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Defense, CTF, US Department of Defense Neurofibromatosis Program.
Abstract (Originalsprache)
Neurofibromatosis 1 (NF1) is a multisymptomatic disorder with highly variable presentations, which include short stature, susceptibility to formation of the characteristic benign tumors known as neurofibromas, intense freckling and skin discoloration, and cognitive deficits, which characterize most children with the condition. Attention deficits and Autism Spectrum manifestations augment the compromised learning presented by most patients, leading to behavioral problems and school failure, while fragmented sleep contributes to chronic fatigue and poor quality of life. Neurofibromin (Nf1) is present ubiquitously during human development and postnatally in most neuronal, oligodendrocyte, and Schwann cells. Evidence largely from animal models including Drosophila suggests that the symptomatic variability may reflect distinct cell-type-specific functions of the protein, which emerge upon its loss, or mutations affecting the different functional domains of the protein. This review summarizes the contributions of Drosophila in modeling multiple NF1 manifestations, addressing hypotheses regarding the cell-type-specific functions of the protein and exploring the molecular pathways affected upon loss of the highly conserved fly homolog dNf1. Collectively, work in this model not only has efficiently and expediently modelled multiple aspects of the condition and increased understanding of its behavioral manifestations, but also has led to pharmaceutical strategies towards their amelioration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Fundamental Biomedical Research, Biomedical Sciences Research Center "Alexander Fleming", 16672 Athens, Greece.
- Laboratory of Experimental Physiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.
ORCID-Profile: Kalliopi Atsoniou, Eleni Giannopoulou, Eirini-Maria Georganta, Efthimios M C Skoulakis
Förderung
- United States Department of Defense
- CTF
- US Department of Defense Neurofibromatosis Program
- Children’s Tumor Foundation Drug Discovery Initiative
Zitieren
APA
Atsoniou, K., Giannopoulou, E., Georganta, E. M., & Skoulakis, E. M. C. (2024). Drosophila Contributions towards Understanding Neurofibromatosis 1. Cells. https://doi.org/10.3390/cells13080721
Vancouver
Atsoniou K, Giannopoulou E, Georganta EM, Skoulakis EMC. Drosophila Contributions towards Understanding Neurofibromatosis 1. Cells. 2024. doi:10.3390/cells13080721
BibTeX
@article{Atsoniou2024,
author = {Atsoniou, Kalliopi and Giannopoulou, Eleni and Georganta, Eirini-Maria and Skoulakis, Efthimios M C},
title = {Drosophila Contributions towards Understanding Neurofibromatosis 1},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13080721}
}
EUVIMED